摘要
Objective: To analyze the role of percutaneous coronary intervention and its value in elderly patients with coronary heart disease. Methods: A total of 88 elderly patients diagnosed with coronary heart disease between June 2022 and June 2023 were recruited and divided into two groups using the random number table method, with 44 cases in each group. The control group received conventional drug therapy, while the observation group received percutaneous arterial interventional treatment in addition to conventional drug therapy. Clinical efficacy, adverse cardiovascular events, cardiac function indicators, and quality of life were observed in both groups. Results: The observation group demonstrated a significantly higher total effective rate and significantly lower adverse cardiovascular events (P < 0.05). Furthermore, after treatment, the observation group showed a higher left ventricular ejection fraction, as well as lower left ventricular end-systolic diameter, left ventricular end-systolic volume, left ventricular end-diastolic diameter, and left ventricular end-diastolic volume (P < 0.05). Additionally, the observation group had higher scores in all eight dimensions of the SF-36 scale (P < 0.05). Conclusion: For elderly patients diagnosed with coronary heart disease, percutaneous coronary intervention can achieve superior clinical efficacy and high safety and can help improve cardiac function indicators and quality of life.
参考
Su D, Xu H, 2023, Analysis of the Efficacy and Safety of Percutaneous Coronary Intervention in Elderly Patients with Coronary Heart Disease. Chinese Practical Medicine, 18(18): 53–56.
Chen Q, Zhang X, 2023, The Application Effect of Percutaneous Coronary Intervention in Patients with Coronary Heart Disease and Heart Failure and Its Impact on Brain Natriuretic Peptide Levels, Inflammatory Factors, and Growth Factors. Clinical Medical Research and Practice, 8(15): 29–32.
Wu M, Li Z, Cui J, et al., 2022, Informed Decision-Making for Percutaneous Coronary Intervention in Patients with Stable Coronary Heart Disease. Chinese Journal of Cardiovascular, 27(2): 145–148.
Chen R, Mu Y, 2023, Stress Status and Its Relationship with Emotion and Cardiac Function in Patients with Coronary Heart Disease After Percutaneous Coronary Intervention. International Journal of Psychiatry, 50(3): 524–526.
Wang Z, Yang L, Sun Q, et al., 2022, Analysis of PCI’s Efficacy and Prognosis in Treating Patients with Chronic Heart Failure and Coronary Heart Disease. Chinese Journal of Evidence-Based Cardiovascular Medicine, 14(1): 87–93.
Zhang X, Li S, Niu S, et al., 2021, Meta-Analysis Comparing Dual and Triple Antithrombotic Therapy After PCI for Coronary Heart Disease Complicated with Atrial Fibrillation. Chinese Journal of Evidence-Based Cardiovascular Medicine, 13(7): 782–787.
Meng H, 2021, Effect of PCI Treatment of Coronary Heart Disease and Chronic Heart Failure on NYHA Cardiac Function Classification. Journal of Mathematical Medicine, 34(8): 1163–1164.
Shi S, 2021, Clinical Effect of Percutaneous Coronary Intervention in Treating Angina Pectoris in the Elderly with Coronary Heart Disease. Chinese Contemporary Medicine, 28(3): 95–97.
Pan X, 2021, Analysis of Prognostic Factors in Elderly Patients with Coronary Heart Disease Treated with PCI. Medical Theory and Practice, 34(8): 1419–1421.
Cao Y, Li T, Chen Y, et al., 2021, Observation on Percutaneous Coronary Intervention in High-Risk Coronary Heart Disease Patients Over 75 Years Old with the Assistance of Extracorporeal Membrane Oxygenation. Chinese Journal of Geriatric Cardiovascular and Cerebrovascular Diseases, 23(1): 34–37.